A phase 1 trial to determine the safety of OPC-108459 administered to subjects with atrial fibrillatio
Phase 1
- Conditions
- Atrial fibrillation
- Registration Number
- JPRN-jRCT2080221673
- Lead Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Patients diagnosed with a diagnosis with paroxysmal and persistent atrial fibrillation
Exclusion Criteria
Heart failure, complication of atrial flutter, history of myocardial infarction and angina pectoris, etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety<br>Pharmacokinetics
- Secondary Outcome Measures
Name Time Method